✦ LIBER ✦

Status of therapeutic apheresis in Europe

✍ Scribed by Hans J. Gurland

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 336 KB
Volume: 6
Category: Article
ISSN: 0733-2459
DOI: 10.1002/jca.2920060209

No coin nor oath required. For personal study only.

✦ Synopsis

The development and future trend of therapeutic apheresis in Europe was analyzed. Demographic data on its distribution were collected with the help of the marketing departments of four commercial companies. The differences in application in European countries were examined and compared with North America and Japan.

📜 SIMILAR VOLUMES

Therapeutic apheresis in Canada

✍ Gail A. Rock; Carole A. Herbert 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

Therapeutic apheresis in neurological di

Therapeutic apheresis in neurological disorders

✍ Robert Weinstein 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB 👁 2 views

Therapeutic apheresis in special populat

Therapeutic apheresis in special populations

✍ Rasheed A. Balogun; Adesola Ogunniyi; Kimberly Sanford; Chidi Okafor; Peter I. L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Apheresis procedures in critically ill patients present a number of challenges to the apheresis team and there are myriad beneficial and adverse effects on patients. Plasmapheresis using a 1 blood volume exchange removes up to 63% of plasma solutes, whereas an exchange using 1.5 blood volumes will r

Therapeutic apheresis in rheumatological

Therapeutic apheresis in rheumatological diseases

✍ Max Hamburger; Gayl Rogers 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 1 views

Dr. Hamburger was asked whether he would recommend the use of cytoxin or lymphacytapheresis first in the treatment of rheumatoid arthritis. He stated that he would recommend lymphacytapheresis first, especially in relatively young patients because of the multiple side effects and the risk of long-te

An overview of therapeutic apheresis in

An overview of therapeutic apheresis in pediatrics

✍ Dolores M. Galacki 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 22 KB 👁 2 views

Therapeutic apheresis in pediatrics requires selected modifications due to the child's smaller size, blood volume, and developmental age. Red blood cell priming is used to prevent dilution of the child's hematocrit from the normal saline prime. Continuous flow cell separators maintain isovolemia. Di

Physician coverage of therapeutic aphere

Physician coverage of therapeutic apheresis

✍ Judith E. Woll 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB 👁 1 views

A "snapshot" survey of physician coverage for evaluation and supervision of therapeutic apheresis procedures shows significant variation in current clinical practice between 39 blood center-and 41 non-blood center-based programs. Whereas 56% of blood center-based programs usually require physician's